COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

Clinical trial NCT00952289 · COMPLETED

Trial details

NCT number: NCT00952289
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

MPN (Myeloproliferative Neoplasms)

Start date: 2009-08-01
Primary completion: 2010-11-01
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.